Hospira Email Format

Pharmaceutical Manufacturing
10,001+ employees
Lake Forest, IL, USA

Hospira is a pharmaceutical manufacturing company that specialized in injectable drugs and infusion technologies before being acquired by Pfizer in 2015.

Find contacts at Hospira

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

first.last@hospira.com

Company Overview

Industry
Pharmaceutical Manufacturing
Founded
2004
Headquarters
Lake Forest, IL, USA
Revenue
$10B-$25B
FUNDING Stage
Acquired
Key Executives
F. Michael Ball (Chief Executive Officer), Thomas E. Werner (Senior Vice President, Finance and Chief Financial Officer)

Tech Stack

Oracle Cloud

Cloud

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Hospira?

Hospira uses the first.last format, so Jane Smith would be jane.smith@hospira.com.

What are the two core business segments that Hospira built its portfolio around?

Hospira organized its business around two main segments: Specialty Injectable Pharmaceuticals, which covered generic acute-care and oncology injectables, and Medication Management, which included infusion pumps and related safety software like Hospira MedNet.

How can I find a specific Hospira contact for outreach?

Since Hospira follows a consistent first.last@hospira.com email pattern, you can build or verify contact details for specific Hospira employees using a tool like Clay, which lets you enrich leads and confirm email addresses at scale.

Where is Hospira headquartered, and when did it become an independent company?

Hospira is headquartered at 275 North Field Drive in Lake Forest, Illinois. The company became an independent publicly traded company in May 2004 after Abbott Laboratories spun off its hospital products division.

Does Hospira have a biosimilar product that received FDA approval?

Yes, Hospira developed Retacrit (epoetin alfa-epbx), which the FDA approved in 2018 as the first biosimilar to Epogen/Procrit for treating anemia associated with chronic kidney disease, chemotherapy, and HIV treatment with zidovudine.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles